Evaluation of visual analog scales for the assessment of symptom severity in allergic rhinoconjunctivitis

Annals of Allergy, Asthma and Immunology

Volumn 98, Issue 2, 2007, Pages 134-138

  Senti, Gabriela ^a,b   Vavricka, Bettina Mareike Prinz ^a   Graf, Nicole ^a   Johansen, Pål ^a   Wüthrich, Brunello ^a   Kündig, Thomas M ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLERGIC RHINITIS; ARTICLE; CORRELATION COEFFICIENT; DISEASE SEVERITY; EVALUATION; FEMALE; GENDER; GRASS POLLEN; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE PROVOCATION TEST; PRIORITY JOURNAL; RHINOCONJUNCTIVITIS; SYMPTOMATOLOGY; VISUAL ANALOG SCALE;

EID: 33846805851     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60685-0     Document Type: Article

References (23)

1. International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet. 1998;351:1225-1232.
2. Arbes SJ Jr, Gergen PJ, Elliott L, Zeldin DC. Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey. J Allergy Clin Immunol. 2005;116:377-383.
3. Borum P, Mygind N. Inhibition of the immediate allergic reaction in the nose by the β-2 adrenostimulant fenoterol. J Allergy Clin Immunol. 1980;66:25-32.
4. Osterballe O. Nasal and skin sensitivity during immunotherapy with two major allergens 19, 25 and partially purified extract of timothy grass pollen. Allergy. 1982;37:169-177.
5. Riechelmann H, Epple B, Gropper G. Comparison of conjunctival and nasal provocation test in allergic rhinitis to house dust mite. Int Arch Allergy Immunol. 2003;130:51-59.
6. Braun-Fahrländer C, Wüthrich B, Gassner M, et al. Validation of a rhinitis symptom questionnaire (ISAAC core questions) in a population of Swiss school children visiting the school health services. Pediatr Allergy Immunol. 1997;8:75-82.
7. Klimek L, Reske-Kunz AB, Mailing HJ. Methods for monitoring of therapeutic efficacy in immunotherapy of allergic rhinitis [in German]. Wien Med Wochenschr. 1999;149:394-402.
8. Huskisson EC. Measurement of pain. Lancet. 1974;2:1127-1131.
9. Wallenstein SL, Heidrich G III, Kaikio R, Houde RW. Clinical evaluation of mild analgesics: the measurement of clinical pain. Br J Clin Pharmacol. 1980;10:319S-327S.
10. Spector SL, Nicklas RA, Chapman JA, et al. Symptom severity assessment of allergic rhinitis: part 1. Ann Allergy Asthma Immunol. 2003;91:105-114.
11. Oldenbeuving NB, KleinJan A, Mulder PG, et al. Evaluation of an intranasal house dust mite provocation model as a tool in clinical research. Allergy. 2005;60:751-759.
12. Riechelmann H, Bachert C, Goldschmidt B, et al. Performance of the nasal provocation test by upper respiratory diseases: a position paper from the German association of allergology and clinical immunology [in German]. Allergo J. 2002;11:29-36.
13. Wüthrich B, Schindler C, Leuenberger P, Ackermann-Liebrich U. Prevalence of atopy and pollinosis in the adult population of Switzerland (SAPALDIA study). Int Arch Allergy Immunol. 1995;106:149-156.
14. Wüthrich B, Schindler C, Medici TC, Zellweger JP, Leuenberger P. IgE levels, atopy markers and hay fever in relation to age, sex and smoking status in a normal adult Swiss population. Int Arch Allergy Immunol. 1996;111:396-402.
15. Roberts G, Mylonopoulou M, Hurley C, Lack G. Impairment in quality of life is directly related to the level of allergen exposure and allergic airway inflammation. Clin Exp Allergy. 2005;35:1295-1300.
16. Rhee JS, Book DT, Burzynski M, Smith TL. Quality of life assessment in nasal airway obstruction. Laryngoscope. 2003;113:1118-1122.
17. Ryden O, Andersson B, Andersson M. Disease perception and social behaviour in persistent rhinitis: a comparison between patients with allergic and nonallergic rhinitis. Allergy. 2004;59:461-464.
18. Berkley KJ. Sex differences in pain. Behav Brain Res. 1997; 20:371-380.
19. Fillingim RB, Edwards RR, Powell T. The relationship of sex and clinical pain to experimental pain responses. Pain. 1999;83:419-425.
20. Rollnik JD, Karst M, Piepenbrock S, Gehrke A, Dengler R, Fink M. Gender differences in coping with tension-type headaches. Eur Neurol. 2003;50:73-77.
21. Smith EL, Hann DM, Ahles TA, et al. Dyspnea, anxiety, body consciousness, and quality of life in patients with lung cancer. J Pain Symptom Manage. 2001;21:323-329.
22. Unruh AM. Gender variations in clinical pain experience. Pain. 1996;65:123-167.
23. Fillingim RB. Sex-related hormone influence on pain and analgesic responses. Neurosci Biobehav Rev. 2000;24:485-501.